New hope for treatment of respiratory involvement following COVID-19 by bromhexine
Abdolrazagh Barzegar, Masoud Ghadipasha, Nima Rezaei, Mehdi Forouzesh, Rohollah Valizadeh
Abstract
Bromhexine as a fluidifying agent can be investigated in clinical trials to discover its therapeutic effect on respiratory involvement following COVID-19.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Respiratory system2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineVirologyTraditional medicineInternal medicineInfectious disease (medical specialty)OutbreakDiseasePharmacological Receptor Mechanisms and EffectsPhenothiazines and Benzothiazines Synthesis and ActivitiesAntibiotics Pharmacokinetics and Efficacy